Foghorn Therapeutics Inc.

US$1.87As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:FHTXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (29.98%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 3.21
PE TTM —
TSR TTM (57.60%)
Mkt cap US$111.1M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.29
22.63%
(69.83%)
Hold 2|5|4|8|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
5.48%
8.48%
1.74%
8.67%
Revenue$M
6.957
6.895
6.715
6.986
3.05%
3.09%
(4.71%)
(2.35%)
Peers (US$111.1M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.160
(0.405)
(0.312)
EBIT/Intx
2.720
0.512
0.355
Own earn%
193.33
(64.58)
(63.26)
Sh yield%
10.67
52.79
50.50
Owners
Insiders/Inst%
14.53
53.00
Short interest%
3.44
SBC / revenue%
3.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
14–23
$1 testx
0.2
Incr. ROIC%
4